Viewray Inc (NASDAQ:VRAY) Receives Consensus Rating of “Hold” from Analysts

Shares of Viewray Inc (NASDAQ:VRAY) have earned an average recommendation of “Hold” from the eleven analysts that are currently covering the company, MarketBeat.com reports. One analyst has rated the stock with a sell rating, four have issued a hold rating and six have given a buy rating to the company. The average 12-month price objective among brokerages that have covered the stock in the last year is $3.64.

Several brokerages recently issued reports on VRAY. BTIG Research reiterated a “hold” rating on shares of Viewray in a report on Wednesday, June 3rd. Cantor Fitzgerald began coverage on Viewray in a report on Monday, June 15th. They issued a “buy” rating and a $3.00 price target for the company. Oppenheimer reiterated a “buy” rating and issued a $3.00 price target on shares of Viewray in a report on Tuesday, June 23rd. Finally, BidaskClub upgraded Viewray from a “sell” rating to a “hold” rating in a report on Thursday, September 10th.

Shares of NASDAQ:VRAY opened at $3.10 on Thursday. The business’s 50 day simple moving average is $2.90 and its 200-day simple moving average is $2.36. The firm has a market capitalization of $458.63 million, a price-to-earnings ratio of -3.48 and a beta of 0.78. The company has a debt-to-equity ratio of 0.26, a current ratio of 3.90 and a quick ratio of 3.19. Viewray has a 12 month low of $1.11 and a 12 month high of $4.88.

Viewray (NASDAQ:VRAY) last announced its quarterly earnings results on Thursday, July 30th. The company reported ($0.18) EPS for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.16) by ($0.02). The firm had revenue of $14.22 million for the quarter, compared to analysts’ expectations of $5.81 million. Viewray had a negative return on equity of 63.41% and a negative net margin of 166.74%. On average, equities analysts anticipate that Viewray will post -0.72 earnings per share for the current year.

A number of large investors have recently bought and sold shares of the business. ProShare Advisors LLC acquired a new position in Viewray in the second quarter worth approximately $34,000. CWS Financial Advisors LLC bought a new position in Viewray in the 2nd quarter worth $39,000. Aperio Group LLC bought a new position in Viewray in the 1st quarter worth $40,000. Jane Street Group LLC raised its holdings in Viewray by 38.8% in the 2nd quarter. Jane Street Group LLC now owns 22,944 shares of the company’s stock worth $51,000 after acquiring an additional 6,410 shares during the period. Finally, Two Sigma Advisers LP bought a new position in Viewray in the 1st quarter worth $56,000. 83.03% of the stock is owned by institutional investors.

Viewray Company Profile

ViewRay, Inc designs, manufactures and markets MRIdian, the magnetic resonance imaging (MRI)-guided radiation therapy system to image and treat cancer patients simultaneously. The Company offers radiation therapy technology combined with magnetic resonance imaging. MRIdian integrates MRI technology, radiation delivery and the Company’s software to locate, target and track the position and shape of soft-tissue tumors while radiation is delivered.

See Also: What are economic reports?

Analyst Recommendations for Viewray (NASDAQ:VRAY)

Receive News & Ratings for Viewray Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Viewray and related companies with MarketBeat.com's FREE daily email newsletter.



Leave a Reply